Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ColoFact ApS
APS
Dissolved
CVR 41925329
Arnegårds Alle 6
Manufacture of medical and dental instruments and supplies · NACE 3250
Est. 2020
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK 728K
-18% vs 2022
EBITDA margin
-22.9%
+41% vs 2022
Equity ratio
-31.0%
Financial strength
Net profit 2023
DKK -171K
+41% vs 2022
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
DKK 728K
-18%
EBITDA
DKK -167K
+41%
Net profit
DKK -171K
+41%
Total assets
DKK 227K
+41%
Equity
DKK -70K
-170%
Employees
1
—
Company information
Legal name
ColoFact ApS
CVR number
41925329
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
2. december 2020
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af alle direktørerne i forening
Contact
Address
Arnegårds Alle 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of medical and dental instruments and supplies
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
Income statement
DKK thousands
Item
2021
2022
2023
Revenue
1.118
887
728
Staff expenses
-665
-1.171
-895
EBITDA
453
-284
-167
Depreciation & amort.
-0
-0
-0
EBIT
453
-284
-167
Net financials
-3
-6
-5
Profit before tax
450
-289
-171
Tax
100
-0
-0
Net profit
350
-289
-171
Balance sheet
DKK thousands
Item
2021
2022
2023
Total assets
678
162
227
Equity
390
101
-70
Long-term debt
0
0
0
Short-term debt
288
61
298
Total debt
288
61
298
Financial ratios
5-year trend
EBITDA margin
-22.9%
This company
15.8%
Market median
-245% vs market
2021
2023
Equity ratio
-31.0%
This company
38.2%
Market median
-181% vs market
2021
2023
Return on equity
-17125700.0%
This company
18.4%
Market median
-93074557% vs market
2021
2023
Net profit margin
-23.5%
This company
8.1%
Market median
-390% vs market
2021
2023
Asset turnover
3.21×
This company
1.12×
Market median
+187% vs market
2021
2023
Debt / equity
4.22×
This company
0.62×
Market median
-581% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-12-02 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Torben Hjorth Petersen
Individual
50.0%
50.0%
2020
Pharmakia Holding ApS
Company
90.0%
90.0%
2020
ProTechTor Holding ApS
Company
5.0%
5.0%
2020
Stephane Laurent Thomas Labrosse
Individual
50.0%
50.0%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ColoFact ApS also hold positions in
0
other companies.
Person
Role here
Other companies